Nerve Growth Factor and Alzheimers Disease
Received Date: Oct 01, 2022 / Accepted Date: Oct 31, 2022 / Published Date: Oct 31, 2022
Abstract
Whim-whams growth factor (NGF) is a well- characterized protein that exerts pharmacological goods on a group of cholinergic neurons known to atrophy in Alzheimer's complaint (announcement). Considerable substantiation from beast studies suggests that NGF may be useful in reversing, halting, or at least decelerating the progression of announcement- related cholinergic rudimentary forebrain atrophy, maybe indeed cheapening the cognitive deficiency associated with the complaint.
Citation: Cumbay MG (2022) Nerve Growth Factor and Alzheimers Disease. Clin Pharmacol Biopharm, 11: 293. Doi: 10.4172/2167-065X.1000293
Copyright: © 2022 Cumbay MG. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 2445
- [From(publication date): 0-2022 - Nov 21, 2024]
- Breakdown by view type
- HTML page views: 2177
- PDF downloads: 268
